StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at Piper Jaffray
November 9, 2017 7:52 AM
Piper Jaffray raised its price target on Amphastar Pharmaceuticals (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Amphastar Pharmaceuticals (AMPH) PT Raised to $17 at BMO Capital on 3Q Report; 'Awaiting Execution With Key Pipeline Opportunities'
November 10, 2017 9:29 AM
Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at Jefferies
November 9, 2017 8:28 AM
Raymond James Downgrades Amphastar Pharmaceuticals (AMPH) to Market Perform
November 9, 2017 4:40 AM
Form 8-K Amphastar Pharmaceutical For: Nov 08
November 8, 2017 4:25 PM
Amphastar Pharma (AMPH) Tops Q3 EPS by 5c
November 8, 2017 4:08 PM
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017
November 8, 2017 4:07 PM
